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Abstract
We present a new estimator of the restricted mean survival time in randomized trials where
there is right censoring that may depend on treatment and baseline variables. The proposed
estimator leverages prognostic baseline variables to obtain equal or better asymptotic preci-
sion compared to traditional estimators. Under regularity conditions and random censoring
within strata of treatment and baseline variables, the proposed estimator has the following fea-
tures: (i) it is interpretable under violations of the proportional hazards assumption; (ii) it is
consistent and at least as precise as the Kaplan-Meier estimator under independent censoring;
(iii) it remains consistent under violations of independent censoring (unlike the Kaplan-Meier
estimator) when either the censoring or survival distributions are estimated consistently; and
(iv) it achieves the nonparametric efficiency bound when both of these distributions are con-
sistently estimated. We illustrate the performance of our method using simulations based on
resampling data from a completed, phase 3 randomized clinical trial of a new surgical treat-
ment for stroke; the proposed estimator achieves a 12% gain in relative efficiency compared to
the Kaplan-Meier estimator. The proposed estimator has potential advantages over existing ap-
proaches for randomized trials with time-to-event outcomes, since existing methods either rely
on model assumptions that are untenable in many applications, or lack some of the efficiency
and consistency properties (i)-(iv). We focus on estimation of the restricted mean survival time,
but our methods may be adapted to estimate any treatment effect measure defined as a smooth
contrast between the survival curves for each study arm. We provide R code to implement the
estimator.
Keywords: Covariate adjustment; Efficiency; Targeted minimum loss based estimation; Ran-
dom censoring.
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1 Introduction
A standard approach to analyze clinical trials with survival outcomes is to estimate the survival
curve in each study arm using the Kaplan-Meier estimator. This approach assumes that the censor-
ing time is independent of the event time for each study arm. This assumption would typically be
false, e.g., if high baseline disease severity is prognostic for both earlier drop-out and earlier time
to death. To accommodate this type of situation, we focus throughout on the weaker assumption
of random censoring, defined as censoring being independent of the event time within strata of the
study arm and baseline variables. This assumption allows informative censoring, i.e., censoring
correlated with the event time in a manner fully explained by study arm and baseline variables.
The Kaplan-Meier estimator is an unadjusted estimator, that is, it ignores baseline variables.
Unadjusted estimators have the following potential drawbacks: (a) they can yield inconsistent esti-
mators of the survival function under informative censoring as discussed above, and (b) even under
independent censoring (defined as censoring independent of event time and baseline variables, for
each arm), they are inefficient if baseline variables are prognostic of the outcome. Appropriate ad-
justment for baseline variables provides an opportunity to avoid these drawbacks by (a) providing
consistent estimators of the treatment effect under random censoring and consistent estimation of
either the censoring or survival distribution, and (b) increasing efficiency (i.e., asymptotic preci-
sion) of the estimators, thereby decreasing the required sample size and saving resources.
A commonly used method to analyze randomized trials with survival outcomes is the propor-
tional hazards model (Cox, 1972). A drawback of this approach is that the treatment effect estimate
becomes uninterpretable and may be misleading under violations of the proportional hazards as-
sumption (Schemper, 1992; Tian et al., 2014). These violations are not necessarily easy to detect,
and can lead to false conclusions in an otherwise well designed and executed randomized trial.
Several alternatives are available to define the effect of assignment to treatment versus control
on a survival outcome. We focus on estimation of the marginal (i.e., unconditional) treatment
effect defined as the difference between the restricted mean survival time (RMST) in the two study
arms. The RMST is the expected survival time restricted to (i.e., truncated at) a time τ . This
parameter has a model-free, clinically meaningful interpretation (Chen and Tsiatis, 2001; Royston
and Parmar, 2011; Zhao et al., 2012; Tian et al., 2014). For example, if τ = 180 days, then a 14
day improvement in RMST due to treatment means 2 more weeks alive on average during the first
6 months; this may be more directly interpretable than a hazard ratio.
Although we focus on the RMST, our methods may be adapted to estimation of any smooth
contrast between the marginal survival curves for each study arm. For example, the difference
between the restricted median survival times may be of interest, e.g., for heavy-tailed survival
times. An alternative goal, not considered here, is to estimate a conditional effect of treatment, i.e.,
a contrast between distributions conditioned on the values of certain baseline variables. Though
our ultimate goal is to estimate unconditional treatment effects, we harness information in baseline
variables both to handle informative censoring (which could lead to bias if ignored) and to adjust
for chance imbalances between study arms (to improve precision).
Our methods assume the outcome is observed on a discrete time scale. If the outcome is
measured on a continuous time scale, our proposal may still be used by finely discretizing time. In
our motivating example, we observe time at the day level, and consider a period of τ = 180 days.
Existing estimators for our problem can be broken into the following three families: methods
based on modeling the survival function conditional on treatment and baseline variables (referred to
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as outcome regression models), methods based on modeling the censoring probability conditional
on treatment and baseline variables, and methods called doubly robust estimators that combine
these models. We describe these in Section 2 where we show existing methods lack one or more
of the features (i)-(iv) in the abstract.
We propose a new doubly robust estimator of the RMST with all the properties in the abstract,
which is derived using the general targeted minimum loss based estimation (TMLE) framework
of van der Laan and Rubin (2006). Our estimator combines key ideas from Moore and van der
Laan (2009a), Rotnitzky et al. (2012), and Gruber and van der Laan (2012), as we describe in
Section 6. To the best of our knowledge, our proposed estimator is the first to achieve properties
(i)-(iv) simultaneously for our problem.
In Section 2, we review commonly used methods for our problem and highlight their strengths
and limitations. In Section 3, our motivating application is presented: the analysis of a completed
Phase III randomized trial of a new treatment for stroke. In Sections 4 and 5, we define our estima-
tion problem and present estimators from related work, respectively. In Section 6, we present our
new estimator. Simulation studies are presented in Section 7, based on our motivating application.
These simulation studies demonstrate that our estimator can lead to substantial improvements in
efficiency. We conclude with a brief discussion and directions of future research.
2 Related Work
Various methods have been proposed that satisfy some but not all of the properties (i)-(iv) from the
abstract. Zhang (2014) propose a method to estimate the survival function at a single time point, by
using a linear working model for the outcome. A working model is defined as a statistical model
used to construct an estimator, but that is not necessarily assumed to be correctly specified. Unlike
our proposal, the method of Zhang (2014) requires censoring to be independent of the event time
within each study arm. In addition, unlike our estimator, their method requires outcome regression
models to be linear (and not, e.g., logistic). Parast et al. (2014) propose an estimator that adjusts for
covariates through a kernel regression of the outcome on a one-dimensional dimension reduction
defined as the linear predictor of a proportional hazards model. Their estimator achieves properties
(i)-(ii), but not (iii)-(iv).
Lu and Tsiatis (2011, Section 3) give a general approach for constructing estimators using
longitudinal data. Their approach, if it were applied to estimate the RMST, would have properties
(i)-(ii), but not (iii)-(iv). Unlike here, they require the censoring distribution to be known. An
advantage of their estimator over our proposal is the incorporation of post-baseline covariates to
adjust for time dependent confounding (i.e., when censoring and the event time have time-varying
common causes). Though we do not address this problem, the techniques in this paper may be
generalized to accommodate such scenarios. Stitelman et al. (2011) also handle time dependent
confounding for survival outcomes; their estimator has properties (i), (iii), (iv) but not (ii).
Methods based on estimating the censoring distribution (Cole and Herna´n, 2004; Xie and Liu,
2005; Rotnitzky and Robins, 2005) are consistent under correct specification of the censoring
model. However, these estimators are typically not as efficient as the covariate adjusted estimators
described later, and thus do not fully leverage the often expensive data collected in a clinical trial.
Under consistent estimation of the censoring and outcome distributions at rate faster than n1/4,
doubly robust estimators are asymptotically efficient in the nonparametric model that only assumes
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treatment is assigned independent of baseline variables (Robins and Rotnitzky, 1992; Hubbard
et al., 2000; van der Laan and Robins, 2003; Moore and van der Laan, 2009a; Stitelman et al.,
2011). Under outcome regression model misspecification but correct censoring model specifica-
tion, doubly robust estimators remain consistent but they can be inefficient with variance larger
than the variance of inverse probability weighted estimators. Under independent censoring, they
can also have variance larger than unadjusted alternatives such as the Kaplan-Meier estimator. (A
large sample illustration, for a related problem, is in the Web Appendix of Dı´az et al., 2015). This
is problematic since there is no guarantee that the effort placed in constructing adjusted estimators
will lead to improved precision in estimation of the treatment effect.
The efficiency theory that we develop has roots in the work of Pfanzagl and Wefelmeyer (1985);
Robins and Rotnitzky (1992); Robins et al. (1994); Bickel et al. (1997); Hahn (1998); Scharfstein
et al. (1999); Bang and Robins (2005), among others who laid the foundation for locally efficient
estimation of causal effects. Their methods have been extended to incorporate enhanced efficiency
properties, e.g., by Tan (2006); van der Laan and Rubin (2006); Zhang et al. (2008); Tsiatis et al.
(2008); Cao et al. (2009); Tan (2010); Rotnitzky et al. (2012); Gruber and van der Laan (2012).
We use the general framework of van der Laan and Rubin (2006) and Gruber and van der
Laan (2012) to construct a targeted minimum loss based estimator of the RMST that satisfies the
properties described in the abstract. Targeted minimum loss based estimation (TMLE) of the effect
of treatment on binary, continuous, and time to event outcomes in randomized trials was discussed
in Moore and van der Laan (2009b) and Stitelman et al. (2011). Based on the work of Gruber and
van der Laan (2012), Dı´az et al. (2015) proposed a TMLE for ordinal outcomes with enhanced
efficiency properties analogous to those of the estimator we propose in this manuscript.
The general estimation approach of Moore and van der Laan (2009a) has properties (i), (iii),
(iv), but not (ii). Our main innovation is to enhance this approach so that it also achieves (ii).
The enhancement is not trivial to achieve, and relies on the general strategy from Rotnitzky et al.
(2012) and Gruber and van der Laan (2012), whose work builds on enhanced efficiency methods
described above.
3 Motivating Application: CLEAR III Trial
The CLEAR III trial (Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemor-
rhage Phase III) is a completed Phase III multicenter randomized controlled trial. 500 individuals
with intraventricular hemorrhage (IVH) were randomized with equal allocation to receive either
alteplase (treatment) or saline (control) for IVH removal. The primary outcome was defined as a
score of 3 or less on the modified Rankin Scale (mRS) of functional disability at 180 days (where
smaller values correspond to better function). The proportions with mRS at most 3 at 180 days
were 48% vs. 45% in the treatment vs. control arms, respectively. A key secondary outcome was
all-cause mortality at 180 days: 18% and 29% of patients experienced death by 180 days in the
treatment vs. control arms, respectively. Though covariate adaptive randomization was used to
assign study arms, we ignore this in illustrating our method.
We reanalyzed data from the CLEAR III trial by defining the outcome as time to death in days
from randomization, and the treatment effect as the difference in the RMST (at τ = 180 days)
comparing treatment versus control arms. Figure 1 displays the estimated Kaplan-Meier survival
curve for each study arm. Using the Kaplan-Meier estimator, the unadjusted estimate of the differ-
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ence in the RMST is 14.9 days (with standard error 5.5). The CLEAR III investigators identified
several baseline variables believed to be prognostic for mortality; these include age, the Glasgow
Coma Score (GCS), the National Institute of Health Stroke Scale (NIHSS) score, intracerebral
hemorrhage (ICH) location (thalamus vs. other) and ICH volume. After adjusting for these base-
line variables using our proposed method described in Section 6, the estimated difference in the
RMST is 14.6 days (with standard error 5.2). Our adjusted estimator yields an estimated variance
that is roughly 12% smaller than the (unadjusted) RMST difference based on the Kaplan-Meier
estimator. In the context of the CLEAR III trial, such a precision gain would allow a reduction
by approximately 60 (out of original 500) patients in the required sample size to achieve a desired
power, if a Wald-test were used based on the adjusted versus the unadjusted estimator.
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Figure 1: Kaplan-Meier survival curves for the treatment arm (solid line) and control arm (dashed
line) of the CLEAR III trial
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4 Data Structure, RMST Parameter, and Identification
4.1 Observed Data Structure for Each Participant
Assume K equally spaced time points t = {1, . . . , K}, e.g., representing days, at which partici-
pants are monitored. Let T denote a discrete, time-to-event outcome taking values in {1, . . . , K}∪
{∞}, where T = ∞ represents no event occurring during times 1, . . . , K. Let C ∈ {0, . . . , K}
denote the censoring time defined as the time at which the participant is last observed in the study;
if a participant remains on study through time point K, we let C = K, which represents admin-
istrative censoring. Let A ∈ {0, 1} denote study arm assignment, and let W denote a vector of
baseline variables. The observed data vector for each participant is O = (W,A,∆, T˜ ), where
T˜ = min(C, T ), and ∆ = 1{T ≤ C} is the indicator that the participant’s event time is observed
(uncensored). Here 1(X) is the indicator variable taking value 1 if X is true and 0 otherwise.
We assume the observed data vector for each participant i, denoted Oi = (Wi, Ai,∆i, T˜i), is an
independent, identically distributed draw from the unknown joint distribution P0 on (W,A,∆, T˜ ).
We assume P0 ∈ M, where M is the nonparametric model defined as all continuous densities
on O with respect to a dominating measure ν such that A is independent of W , which holds by
randomization. Our asymptotic results are in the limit as sample size n goes to infinity, with the
number of time points K being fixed.
We can equivalently encode a single participant’s data vector O using the following longitudi-
nal data structure:
O = (W,A,R0, L1, R1, L2 . . . , RK−1, LK), (1)
where Rt = 1{T˜ = t,∆ = 0} and Lt = 1{T˜ = t,∆ = 1}, for t ∈ {0, . . . , K}. The sequence
R0, L1, R1, L2 . . . , RK−1, LK in the above display consists of all 0’s until the first time that either
the event is observed or censoring occurs, i.e., time t = T˜ . In the former case Lt = 1; otherwise
Rt = 1. For a random variable X , we denote its history through time t as X¯t = (X0, . . . , Xt). For
a given scalar x, the expression X¯t = x denotes element-wise equality. The corresponding vector
(1) for participant i is denoted by (Wi, Ai, R0,i, L1,i, R1,i, L2,i . . . , RK−1,i, LK,i).
Define the following indicator variables for each t ≥ 1:
It = 1{R¯t−1 = 0, L¯t−1 = 0}, Jt = 1{R¯t−1 = 0, L¯t = 0}.
The variable It is the indicator based on the data through time t − 1 that a participant is at
risk of the event being observed at time t; in other words, It = 1 means that all the variables
R0, L1, R1, L2..., Lt−1, Rt−1 in the data vector (1) equal 0, which makes it possible that Lt = 1.
Analogously, Jt is the indicator based on the outcome data through time t and censoring data
before time t that a participant is at risk of censoring at time t. By convention we let J0 = 1.
Define the hazard function for survival at time m ∈ {1, . . . , K}:
h(m, a, w) = P0(Lm = 1|Im = 1, A = a,W = w),
among the population at risk at timem within strata of study arm and baseline variables. Similarly,
for the censoring variable C, define the censoring hazard at time m ∈ {0, . . . , K}:
gR(m, a, w) = P0(Rm = 1|Jm = 1, A = a,W = w).
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We use the notation gA(a, w) = P0(A = a|W = w) and g = (gA, gR). Let pW denote the
marginal distribution of the baseline variables W . We add the subscript 0 to pW , g, h to denote
the corresponding quantities under P0. The joint distribution P0 on the observed data vector O =
(W,A,∆, T˜ ) is completely characterized by the components p0, g0, h0, i.e., P0 = (p0, g0, h0).
4.2 RMST Parameter Definition in Terms of Potential Outcomes
Define the potential outcomes Ta : a ∈ {0, 1} as the event times that would have been observed
had study arm assignment A = a and censoring time C = K been externally set with probability
one. For a restriction time τ ∈ {1, . . . , K} of interest, the target estimand is the difference between
the restricted mean survival time setting study arm to a = 1 versus a = 0:
θc = E{min(T1, τ)−min(T0, τ)}.
The superscript c denotes a causal parameter, that is, a parameter of the distribution of the po-
tential outcomes T1 and T0. We prove in the Supplementary Materials that E{min(Ta, τ)} =∑τ−1
t=0 S
c(t, a), where Sc(t, a) = P (Ta > t) is the survival probability corresponding to the poten-
tial outcome under assignment to arm A = a. As a result, θc may be expressed as
θc =
τ−1∑
t=1
{Sc(t, 1)− Sc(t, 0)}, (2)
since Sc(0, a) = 1 for a ∈ {0, 1}.
4.3 Identification of RMST Parameter θc in Terms of Observed Data Gen-
erating Distribution P0
We show how the RMST parameter θc, which is defined above in terms of potential outcomes, can
be equivalently expressed as a function θ of the observed data distribution P0(W,A,∆, T˜ ), under
the assumptions (a)-(d) below. This is useful since the potential outcomes are not always observed,
in contrast to the observed data vector (W,A,∆, T˜ ) for each participant (whose distribution we can
make direct statistical inferences about); we refer to θ as a statistical parameter, which is shorthand
for saying it is a mapping from the observed data distribution P ∈M to R.
Define the following assumptions:
(a) T = 1(A = 0)T0 + 1(A = 1)T1 (consistency);
(b) A is independent of (Ta,W ), for each a ∈ {0, 1} (randomization);
(c) C is independent of Ta conditional on (A,W ), for each a ∈ {0, 1} (random censoring);
(d) gA,0(a, w) > 0 and gR,0(t, a, w) < 1 whenever the P0-density of W is positive at W = w, for
each a ∈ {0, 1} and t ∈ {0, . . . , τ − 1} (positivity assumption).
We make assumptions (a)-(d) throughout the manuscript. Assumption (a) connects the potential
outcomes to the observed outcome. Assumption (b) holds by design in a randomized trial. As-
sumption (c), which is similar to that in Rubin (1987), means that censoring is random within
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strata of treatment and baseline variables (which we abbreviate as “random censoring”). Assump-
tion (d) states that each treatment arm has a positive probability, and that every time point has a
hazard of censoring smaller than one, within each baseline variable stratum W = w with positive
density under P0.
Denote the survival function for T at time t ∈ {1, . . . , τ − 1} conditioned on study arm a and
baseline variables w by
S(t, a, w) = P (T > t|A = a,W = w). (3)
Similarly, define the following function of the censoring distribution:
G(t, a, w) = P (C ≥ t|A = a,W = w). (4)
Under assumptions (a)-(d), we have T⊥⊥C|A,W and therefore S(t, a, w) and G(t, a, w) have the
following product formula representations:
S(t, a, w) =
t∏
m=1
{1− h(m, a, w)}; G(t, a, w) =
t−1∏
m=0
{1− gR(m, a, w)}. (5)
The potential outcome survival function Sc(t, a) can be equivalently represented in terms of
the observed data distribution as
S(t, a) = EpW
t∏
m=1
{1− h(m, a,W )}, (6)
for t ∈ {1, . . . , K}, a ∈ {0, 1}; equality of Sc(t, a) and the above display follows from (5) and
Sc(t, a) = P (Ta > t) = EpWP (Ta > t|W ) = EpWP (T > t|A = a,W ) = EPWS(t, a,W ),
where the third equality above follows from (a) and (b).
It follows from (2) that the causal parameter θc is equal to the following statistical parameter:
θ =
τ−1∑
t=1
[
EPW
{
t∏
m=1
{1− h(m, 1,W )}
}
− EPW
{
t∏
m=1
{1− h(m, 0,W )}
}]
. (7)
Our goal is to estimate θ based on n independent, identically distributed observations Oi =
(Wi, Ai,∆i, T˜i) drawn from P0. We construct an estimator with properties (i)-(iv) in the abstract.
Since the parameter of interest θ is defined as a function of (pW , h) through (7), a natural esti-
mation strategy would be to plug estimates of pW and h in these formulas. Estimators constructed
in this way are called substitution or plug-in estimators, and have the advantage that they remain
within bounds of the parameter space; this is desirable in estimation of probabilities and other
bounded parameters such as the RMST. Our proposed estimator is a substitution estimator.
Define independent censoring to be C⊥⊥(Ta,W ) | A, for each a ∈ {0, 1}. This is a stronger
(more restrictive) assumption than random censoring. We refer to a censoring mechanismG(t, a, w)
as non-informative if it does not depend on w, and as informative if it depends on w. Under inde-
pendent censoring, G(t, a, w) is non-informative.
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5 Several Estimators of RMST (θ) from Related Work
5.1 Unadjusted Estimators of θ: Kaplan-Meier and Inverse Probability Weighted
Throughout this subsection only, we additionally assume independent censoring. This implies
S(t, a) =
∏t
m=1{1 − h(m, a)} for h(m, a) = P (Lm = 1|Im = 1, A = a), as proved in the
Supplementary Material. Therefore, we have the following simpler representation of θ:
θ =
τ−1∑
t=1
[
t∏
m=1
{1− h(m, 1)} −
t∏
m=1
{1− h(m, 0)}
]
. (8)
The Kaplan-Meier estimator for S(t, a) is defined as
Sˆkm(t, a) =
t∏
m=1
{
1−
∑n
i=1 1{Lm,i = 1, Im,i = 1, Ai = a}∑n
i=1 1{Im,i = 1, Ai = a}
}
, (9)
where we set the above fraction to be 0 if the denominator is 0. The right side of (9) was obtained
by substituting the empirical counterpart of each h(m, a) in the formula for S(t, a) above. The
corresponding Kaplan-Meier estimator of θ is defined analogously, as
θˆkm =
τ−1∑
t=1
{Sˆkm(t, 1)− Sˆkm(t, 0)}.
Since θˆkm is a smooth function of at most 4(τ − 1) empirical means, the delta method (Theorem
3.1 van der Vaart, 1998) implies
√
n(θˆkm − θ) =
1√
n
n∑
i=1
Dkm(Oi) + oP (1),
where, for an observation O,
Dkm(O) = −
τ−1∑
t=1
t∑
m=1
[
(2A− 1)Im
gA(A)G(m,A)
S(t, A)
S(m,A)
{Lm − h(m,A)}
]
(10)
is the influence function of θˆkm. The above influence function Dkm may be derived from Lemma 1
below, noting that the Kaplan-Meier estimator is the maximum likelihood estimator in the nonpara-
metric model where only (A,∆, T˜ ) (and not W ) are measured, and therefore it is asymptotically
linear with influence function equal to the efficient influence function in the model for (A,∆, T˜ ).
As a consequence,
√
n(θˆkm − θ) converges to a mean zero normal distribution with asymptotic
variance Var(Dkm(O)).
This estimator is consistent and efficient for the case where only (A,∆, T˜ ) is observed. How-
ever, the unadjusted estimator is generally inefficient for the case where (W,A,∆, T˜ ) is observed.
Intuitively, this is because the unadjusted estimator fails to leverage the prognostic information in
baseline variables W . Furthermore, under the less restrictive random censoring assumption, the
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unadjusted estimator will generally not be consistent, while adjusted estimators remain consistent
if the censoring distribution is consistently estimated.
We next define the unadjusted, inverse probability weighted (IPW) estimator. Let Gˆkm(t, a)
denote the Kaplan-Meier estimator of the censoring distribution G(t, a) =
∏t−1
m=0{1− gR(m, a)},
defined as
Gˆkm(t, a) =
t−1∏
m=0
[
1−
∑n
i=1 1{Rm,i = 1, Jm,i = 1, Ai = a}∑n
i=1 1{Jm,i = 1, Ai = a}
]
.
The unadjusted IPW estimator of S(t, a) is defined as
Sˆipw(t, a) =
1
n
n∑
i=1
1{Ai = a, R¯t−1,i = 0, L¯t,i = 0}
gˆA(a)Gˆkm(t, a)
,
where gˆA(a) denotes the sample mean of 1{A = a}. Zhao et al. (2016) show that
√
n{Sˆipw(t, a)− Sˆkm(t, a)} = oP (1),
i.e., the asymptotic distributions of these two estimators are equal up to oP (1/
√
n), and the esti-
mator of θ given by θˆipw =
∑τ−1
t=1 {Sˆipw(t, 1)− Sˆipw(t, 0)} also satisfies
√
n(θˆipw − θ) =
1√
n
n∑
i=1
Dkm(Oi) + oP (1).
An important consequence is that both
√
n(θˆkm− θ) and
√
n(θˆipw− θ) converge in distribution to
N(0, σ2km), where σ
2
km = Var(Dkm(O)).
5.2 Covariate Adjustment: Inverse Probability Weighted Estimators
Consider an estimator hˆ(t, a, w) for the outcome hazard function h(t, a, w), for example, based on
fitting a Cox proportional hazards model that conditions on A = a and W = w, and that uses
the Nelson-Aalen estimator for the baseline hazard. If the proportional hazards model is correct,
the corresponding substitution estimator based on (7) is consistent for θ. However, under model
misspecification, this substitution estimator will generally be inconsistent. This is particularly
problematic for randomized trials with independent censoring, in which an unadjusted, consistent
estimator can be obtained through the Kaplan-Meier survival function.
As an alternative, an adjusted, inverse probability weighted (IPW) estimator of S(t, a) (where
here and below we use the definition of S(t, a) in (6)) is given by
Sˆadj,ipw(t, a) =
1
n
n∑
i=1
1{Ai = a, R¯t−1,i = 0, L¯t,i = 0}
gˆA(a,Wi)Gˆ(t, a,Wi)
,
where gˆA(a, w) and Gˆ(t, a, w) are estimators of gA(a, w) andG(t, a, w), respectively. The adjusted
IPW estimator of the τ -restricted mean survival time, given by θˆadj,ipw =
∑τ−1
t=1 {Sˆadj,ipw(t, 1) −
Sˆadj,ipw(t, 0)}, is consistent for θ if the estimators (gˆA, gˆR, hˆ) are consistent at a fast enough rate.
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We focus on the case where gˆR(t, a, w) and gˆ(a, w) are estimators having saturated terms for
time, treatment, and their interaction. We define such estimators as estimators that satisfy∑n
i=1 Jm,i{Rm,i − gˆR(m,Ai,Wi)} =
∑n
i=1AiJm,i{Rm,i − gˆR(m,Ai,Wi)} =
∑n
i=1{Ai − gˆA(1,Wi)} = 0,
for m = 0, . . . , K−1. An example of estimators with saturated terms for time, treatment and their
interaction is given by maximum likelihood estimators for logistic regression models of gR(t, a, w)
and gA(a, w), respectively, that include at least an intercept, main terms for A and each time t ∈
{1, . . . , K}, and interaction terms for A by each time t ∈ {1, . . . , K}; arbitrary and data-adaptive
additional terms involving t, a, w can be included in these models.
When using Gˆ(t, a, w) and gˆ(a, w) estimated with such saturated terms, under independent
censoring, Sˆadj,ipw(t, a) is consistent for S(t, a). If these models contain no terms involving w,
then Sˆadj,ipw(t, a) and Sˆipw(t, a) (both using the corresponding estimators Gˆ and gˆ) are identi-
cal. Williamson et al. (2014) use this observation to show that, under independent censoring, the
asymptotic variance of Sˆadj,ipw(t, a) is smaller or equal than the asymptotic variance of Sˆipw(t, a);
this, together with the delta method, implies
√
n(θˆadj,ipw − θ)→ N(0, σ2adj,ipw),
where σ2adj,ipw ≤ σ2km. (Throughout,→ indicates convergence in distribution as n goes to infinity.)
A weakness of θˆadj,ipw is that under informative censoring, it will generally be inconsistent if the
model for G is misspecified. This motivates considering double robust estimators described in
Section 5.3.
Adjusted estimators (such as the adjusted IPW above) often involve fitting a parametric model
for gA, even though gA is known by design in a randomized trial. Intuitively, the purpose of this
model fit is to capture chance imbalances of the baseline variables W between study arms for a
given data set; these imbalances can then be adjusted to improve efficiency. The general theory
underlying efficiency improvements through estimation of known nuisance parameters such as gA
is presented, e.g., by Robins et al. (1994) and van der Laan and Robins (2003).
5.3 Augmented Inverse Probability Weighted (Double Robust) Estimator
We start by presenting the efficient influence function for estimation of θ in modelM. The fol-
lowing lemma may be proved by applying the delta method to the definition of θ in (7) and using
the efficient influence function of S(t, a) as presented in Moore and van der Laan (2009a):
Lemma 1. The efficient influence function for estimating θ in the modelM is
D(O) =
τ−1∑
m=1
[
ImZ(m,A,W ) {Lm − h(m,A,W )}+ S(m, 1,W )− S(m, 0,W )
]− θ, (11)
where Z(m,A,W ) = Z1(m,A,W )− Z0(m,A,W ), and
Za(m,A,W ) = −
τ−1∑
t=m
1{A = a}
gA(a,W )G(m, a,W )
S(t, a,W )
S(m, a,W )
. (12)
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For conciseness, we suppress the dependence of D on g and h. The function D has two
important properties for estimation of θ. First, it is a doubly robust estimating function, i.e., for
given estimators hˆ and gˆ of h and g = (gA, gR), respectively, the estimator formed by solving for θ
in the following estimating equation is consistent if at least one of h or g is estimated consistently
(while the other converges to a limit that may be incorrect):
0 =
n∑
i=1
{ τ−1∑
m=1
[ τ−1∑
t=m
−(2Ai − 1)Im,i
gˆA(Ai,Wi)Gˆ(m,Ai,Wi)
Sˆ(t, Ai,Wi)
Sˆ(m,Ai,Wi)
{Lm,i − hˆ(m,Ai,Wi)}
+ Sˆ(m, 1,Wi)− Sˆ(m, 0,Wi)
]
− θ
}
, (13)
where Sˆ(m, a, w) =
∏m
m′=1{1− hˆ(m′, a, w)} and Gˆ(m, a, w) =
∏m−1
m′=0{1− gˆR(m′, a, w)}. This
estimator is often referred to as the augmented IPW estimator, and we denote it by θˆaipw. The
double robustness property is desirable since it guarantees that improper adjustment for covariates
through a misspecified working model for h still leads to a consistent estimator of θ in randomized
trials with random censoring if gR is consistently estimated.
Second, the efficient influence function (11) characterizes the information bound for estimation
of θ in the modelM (Bickel et al., 1997). Specifically, under consistent estimation of h and g at
a sufficiently fast rate, θˆaipw has variance smaller or equal to that of any regular, asymptotically
linear estimator of θ inM (a property called local efficiency); in this case, if independent censoring
holds, then θˆaipw has equal or smaller asymptotic variance compared to θˆkm. Unfortunately, under
misspecification of the model for h, the estimator of h will generally be inconsistent, which could
lead to θˆaipw having worse asymptotic efficiency than θˆkm under independent censoring. In other
words, the added robustness of θˆaipw may come at the price of lower efficiency compared to θˆkm.
This motivates the question of whether this added robustness can be achieved at no cost. I.e., can
we construct a doubly robust estimator with the added guarantee of equal or better asymptotic
precision as θˆkm if independent censoring holds? We construct such an estimator below.
6 Proposed Estimator
We develop a doubly robust estimator, denoted θˆadj,eff that has properties (i)-(iv) of the abstract.
We will sometimes use the following modified representation of the data set:
{(m,Wi, Ai, Jm,i, Rm,i, Im+1,i, Lm+1,i) : m = 0, . . . , K − 1; i = 1, . . . , n}. (14)
This data set is referred to as the long form, and the original data set
{(Wi, Ai,∆i, T˜i) : i = 1, . . . , n} (15)
is referred to as the short form. An observation in the long form data set is a vector of the form
(m,Wi, Ai, Jm,i, Rm,i, Im+1,i, Lm+1,i). We define the following auxiliary variables:
12
M(W ) =
τ−1∑
t=1
[
S(t, 1,W )
gA(1,W )
+
S(t, 0,W )
gA(0,W )
]
, (16)
H(m,A,W ) =−
τ−1∑
t=m+1
(2A− 1)
gA(A,W )
S(t, A,W )
S(m,A,W )
1
G(m+ 1, A,W )
. (17)
These auxiliary covariates are constructed from a decomposition of the efficient influence function
targeting improved efficiency of the estimators as described after Theorem 2 below.
Our proposed estimator θˆadj,eff is defined as the output of the following algorithm (which fol-
lows the TMLE template):
Step 1. Initial estimators. Obtain initial estimators gˆA, gˆR, and hˆ of gA, gR, and h, respectively.
Let pˆW denote the empirical distribution of W .
Step 2. Iteratively update estimates of h and g. Initialize l = 0, and let hˆl = hˆ, gˆlA = gˆA, gˆ
l
R = gˆR.
(a) Update hˆl. Let Sˆl, Gˆl denote S,G after substituting hˆl, gˆlR, pˆW for h, gR, pW in (5)
and (7). Augment each observation in the long form data set (14) by two covariates
Zˆ la(m,Ai,Wi) : a ∈ {0, 1}, where each Zˆ la(m,Ai,Wi) is constructed by substituting
the estimates Sˆl, Gˆl, gˆlA evaluated at (m,Ai,Wi) in (12). Estimate the parameter vector
 = (1, 0) in the logistic hazard submodel hl for h:
logithl(m, a, w) = logit hˆ
l(m, a, w) + 1Zˆ
l
1(m, a, w) + 0Zˆ
l
0(m, a, w), (18)
by computing the following maximum likelihood estimator:
ˆ = argmax

n∑
i=1
τ−1∑
m=1
Im,i log
{
hl(m,Ai,Wi)
Lm,i(1− hl(m,Ai,Wi))1−Lm,i
}
. (19)
The maximizer ˆ can be computed using standard statistical software by a logistic
regression of Lm,i on the variables Z l1(m,Ai,Wi), Zˆ
l
0(m,Ai,Wi) among observations
with Im,i = 1 and m < τ in the long form data set (14), and using logit hˆl(m,Ai,Wi)
as an offset. Define hˆl+1 = hlˆ.
(b) Update gˆlR. Let Hˆ
l(m,A,W ) denote H(m,A,W ) with Sˆl, Gˆl, gˆlA substituted for
S,G, gA, respectively, in (17). Augment each observation in the long form data set
(14) by Hˆ l(m,Ai,Wi). In the long form data set, estimate the parameter γ in the
following logistic regression submodel for gR(m, a, w):
logit glR,γ(m, a, w) = logit gˆ
l
R(m, a, w) + γHˆ
l(m, a, w), (20)
by logistic regression of Rm,i on the single covariate Hˆ l(m,Ai,Wi) and with offset
logit gˆlR(m,A,W ) among observations with m < τ − 1 and Jm,i = 1. Denote the
corresponding maximum likelihood estimate of γ by γˆ.
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(c) Update gˆlA. Let Mˆ
l(W ) denote M(W ) with gˆlA, Sˆ
l substituted for the corresponding
components in (16). Augment each observation in the short form data set by Mˆ l(Wi).
In the short form data set, estimate the parameter ν in the following logistic regression
submodel for gA(1|w):
logit glA,ν(1|w) = logit gˆlA(1|w) + νMˆ l(w), (21)
by logistic regression of Ai on the covariate Mˆ l(Wi) and with offset logit gˆlA(1|Wi)
among all participants i = 1, . . . , n. Denote the corresponding maximum likelihood
estimate of ν by νˆ.
Define hˆl+1 = hlˆ, gˆ
l+1
R = g
l
R,γˆ , and gˆ
l+1
A = g
l
A,νˆ .
Step 3. Update l = l + 1 and iterate the previous step until convergence. We stop at the first
iteration for which the sample mean of the squared differences of predictions based on hˆl,
gˆlR, gˆ
l
A between step l and step l + 1 is smaller or equal to 10
−4/n.
Denote hˆ?, gˆ?A, and gˆ
?
R the estimators obtained in the last iteration of the above algorithm, and
define the enhanced efficiency TMLE estimator of θ as
θˆadj,eff =
τ−1∑
t=1
[
1
n
n∑
i=1
t∏
m=1
{
1− hˆ?(m, 1,Wi)
}
− 1
n
n∑
i=1
t∏
m=1
{
1− hˆ?(m, 0,Wi)
}]
. (22)
The above display is the substitution estimator of θ based on (7) where the sample means over base-
line variables Wi, i = 1, . . . , n correspond to expectation with respect to the empirical distribution
of W .
We next consider ways to construct the initial estimators of h and g for step 1 above. The
outcome hazard function h may be estimated by running a prediction algorithm for the probability
of Lm = 1 as a function of A, W , and m among observations with Im = 1 in the long form data
set (14). The censoring hazard gR may be estimated by running an analogous prediction algorithm
of the probability that Rm = 1 as a function of A, W , and m among observations with Jm = 1.
The treatment mechanism gA may be estimated by fitting a parametric model for the probability
of A = 1 as a function of W in the short form data set. In a randomized trial, gA is set by design.
However, efficiency of the TMLE can be improved by estimating gA using, e.g., the proportion of
individuals in the treatment group, or a logistic regression model that contains baseline variables
and an intercept term.
Having defined the estimation algorithm, we now present our main results giving conditions
under which θˆadj,eff is guaranteed to be at least as efficient as θˆadj,ipw and θˆkm.
Theorem 1 (Equal or greater asymptotic efficiency compared to adjusted IPW estimator). Assume
(a)-(d), gˆ?A, and gˆ
?
R are n
1/2-consistent inL2(P0) norm, and hˆ? converges to some limit h1 inL2(P0)
norm as n→∞. Then we have the following convergence in distribution results:
√
n(θˆadj,eff − θ)→ N(0, σ2adj,eff),
√
n(θˆadj,ipw − θ)→ N(0, σ2adj,ipw),
where σ2adj,eff ≤ σ2adj,ipw. In addition, if h1 equals the true h0, then θˆadj,eff achieves the semipara-
metric efficiency bound inM.
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The consistency rates required in our previous theorem are more restrictive than necessary to
obtain the convergence in distribution
√
n(θˆadj,eff − θ) → N(0, σ2adj,eff). In the Supplementary
Materials we present a more general theorem, along with its proof, which shows that this conver-
gence holds under standard, less restrictive, doubly robust convergence assumptions on (gˆ?, hˆ?).
The following is our main result:
Theorem 2 (Equal or greater asymptotic efficiency compared to Kaplan-Meier estimator, under
independent censoring). Assume (a)-(d), independent censoring, and that hˆ? converges as in the
first sentence of Theorem 1. Assume also that gˆ?A, gˆ
?
R are estimated using models with saturated
terms for time, treatment, and their interaction. Then
√
n(θˆadj,eff − θ)→ N(0, σ2adj,eff),
√
n(θˆipw − θ)→ N(0, σ2km),√
n(θˆadj,ipw − θ)→ N(0, σ2adj,ipw),
√
n(θˆkm − θ)→ N(0, σ2km),
where σ2adj,eff ≤ σ2adj,ipw ≤ σ2km.
These results guarantee that the proposed TMLE has asymptotic variance that never exceeds
that of the Kaplan-Meier estimator, under independent censoring (when the latter is consistent).
To the best of our knowledge, this is the first estimator to achieve the properties in the previous
theorems for our problem.
The algorithm above (i.e., steps 1-3 and the formula (22)) that generates the TMLE θˆadj,eff
combines key ideas from Moore and van der Laan (2009a), Rotnitzky et al. (2012), and Gruber and
van der Laan (2012). Moore and van der Laan (2009a) present a TMLE algorithm for estimating
the survival difference S(t, 1)−S(t, 0) in the modelM, which involves a step similar to 2a above;
this estimator has properties (i), (iii), and (iv) but not (ii). The crux of our approach to achieve
property (ii) (without sacrificing the other properties) is to augment the censoring and treatment
models through steps 2b and 2c. These augmented models use the covariates (16)-(17) that were
specifically constructed to achieve property (ii).
The idea of augmenting censoring and treatment models to achieve enhanced efficiency prop-
erties can be traced back at least to Robins et al. (1994). More recently, Rotnitzky et al. (2012) built
on this idea to construct an estimator that has equal or better asymptotic precision than a certain
parametric family of estimators including the adjusted IPW estimator, and then Gruber and van der
Laan (2012) showed how to do the same in the TMLE framework.
It is not trivial to determine precisely how to augment the censoring and treatment models
in order to guarantee (ii) holds. We explain the intuition for how we achieved this, which uses
general ideas from the above related work. Assume the conditions in Theorem 1. First, consider
the simpler case where the censoring and treatment distributions gR, gA are known. Define the
simplified TMLE to be as in steps 1-3 above, except omitting steps 2b and 2c and using the known
gR, gA in step 2a. The simplified TMLE’s influence function equals the influence function of the
adjusted IPW estimator minus the following expression (derived in the Supplementary Materials):
M(W ) [A− gA(1,W )] +
τ−2∑
m=0
JmH(m,A,W ) [Rm − gR(m,A,W )] , (23)
for M and H the auxiliary variables in (16) and (17), respectively.
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Second, consider the case where the censoring and treatment distributions gR, gA are unknown
and estimates gˆR, gˆA are used by the TMLE that involves all of steps 1-3, called the enhanced
efficiency TMLE (i.e., θˆadj,eff). The influence function for θˆadj,eff equals that of the simplified
TMLE minus the latter’s projection on the tangent space Tg∗ spanned by the scores of the models
used to estimate gR, gA. (See van der Vaart (1998, Section 25.3) for background on tangent spaces
and projections as used here.) Subtracting off such a projection is helpful since it can only decrease
or leave unchanged the influence function’s variance, which equals the asymptotic variance of
the estimator. By augmenting the model for gR by H as in (20) in step 2b, the corresponding
score is the second term in (23); by augmenting the model for gA by M as in (21) in step 2c, the
corresponding score is the first term in (23). This implies (23) is in the tangent space Tg∗ , and
therefore the influence function for θˆadj,eff is orthogonal to (23). Combining the above argument
with the last line in the previous paragraph, it follows that the influence function for θˆadj,eff equals
the adjusted IPW influence function minus the latter’s projection on Tg∗ . Therefore, θˆadj,eff has
asymptotic variance at most that of the adjusted IPW estimator, which gives the main conclusion
of Theorem 1. Theorem 2 then follows from the asymptotic equivalence of the adjusted IPW and
Kaplan-Meier estimators under the added assumptions of independent censoring and the model for
gR being saturated as described above. A more detailed argument that fleshes out and justifies the
above outline is in the Supplementary Materials.
In addition to the efficiency properties stated in the above results, our estimator inherits the
doubly robust property of the Moore and van der Laan (2009a) TMLE (i.e., the TMLE above
but without steps 2b and 2c). Under random censoring, this means that our proposal has two
opportunities to achieve consistency in estimating the causal effect, in contrast to the proportional
hazard model which relies exclusively on the assumption that the outcome regression is correctly
specified.
Under the assumptions of Theorem 1, for a consistent estimate σˆadj,eff, a Wald-type confidence
interval θˆadj,eff ± zα/2σˆadj,eff/
√
n is guaranteed to have 1 − α asymptotic coverage probability.
If the initial estimators hˆ and gˆR in step 1 are M -estimators (e.g., if they are estimated through
maximum likelihood in parametric working models), the nonparametric bootstrap (Efron et al.,
1979) may be used to obtain a consistent estimate σˆadj,eff (see Corollary 3.1 and 3.2 in Wellner
and Zhan, 1996). The performance of the nonparametric bootstrap is unknown when hˆ or gˆR are
data-adaptive estimators (e.g., if hˆ involves variable selection). The development of a consistent
variance estimator in this case remains an open question.
7 Simulation Study
7.1 Data Generating Distributions
Our simulated distributions are based on resampling data from the CLEAR III trial (described in
Section 3) in order to mimic key features of the trial. The baseline variables for each participant are
W = (W1,W2,W3,W4,W5) = (age, GCS, NIHSS score, ICH location, ICH volume), each scaled
to have mean 0 and standard deviation 1. The outcome is time until death in days, denoted by T .
Define the treatment effect θ to be the difference in the RMST at restriction time τ = 180 days.
We compare the performance of the following estimators defined above: Kaplan-Meier, unadjusted
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IPW, adjusted IPW, augmented IPW (AIPW), and proposed TMLE. The adjusted IPW is referred
to simply as IPW. We ran simulations at two sample sizes: n = 500 and n = 2000.
We consider twelve data generating distributions, where we vary the correlation between T
and W (using 3 scenarios labeled A, B, C defined below), the treatment effect θ, and the censoring
mechanism. Some of these are set to mimic features of the CLEAR III data, as described below.
For each data generating distribution and sample size, we generated 10,000 simulated data sets,
and report on the empirical distribution of each estimator.
The key feature that determines the magnitude of precision gains for the adjusted estimators is
how correlated the baseline variables are with the outcome. To give a rough sense of the observed
correlations in the CLEAR III trial data set, we fit a logistic regression model for the hazard of death
that includes time, treatment, time by treatment interactions, and main effects for each baseline
variable in W = (W1,W2,W3,W4,W5). We report exp(βˆj) : j = 1, 2, 3, 4, 5, where βˆj is the
estimated coefficient for Wj in the model fit. These were 1.5, 0.9, 1.7, 1.0, and 1.1, respectively.
We do not assume the above model is correct; we only used it to roughly measure correlations in
the CLEAR III data set. In our simulations, the data generating distributions for scenario A mimic
the above correlations; in scenarios B and C, the correlations are reduced as described below.
In each simulated trial, the data vector (W,A, T, C) for each participant is generated as an inde-
pendent, identically distributed draw from a joint distribution P that satisfies assumptions (a)-(d).
This distribution will depend on the scenario A-C, censoring mechanism, and treatment effect θ.
For scenario A, each simulated participant’s data vector is generated by first resampling a partic-
ipant with replacement from the CLEAR III data among the 491 patients who did not drop out,
and recording only his/her pair (W,T ). The resulting distribution preserves the empirical correla-
tion between W and T from the CLEAR III trial. Such resampling may lead to more realistically
complex distributions than drawing from a regression model fit for T given W . In each scenario B
and C, we generate an initial (W,T ) as just described, and with probability 0.5 and 1, respectively,
we replace W by an independent draw (with replacement) from the marginal distribution of W in
the CLEAR III trial. The impact is that the correlation between T and W decreases as one pro-
ceeds from scenario A to scenario C, with scenario C having T and W independent (i.e., baseline
variables not prognostic for the outcome).
Next, we assignA independent of (W,T ) by a Bernoulli draw with probability 0.5 of being 1 or
0. This ensures that the randomization assumption (b) holds, and induces a distribution with θ = 0
(no treatment effect). We also consider distributions with a positive treatment effect (θ = 14.9);
this value was selected since it is the unadjusted Kaplan-Meier estimate of θ from the CLEAR III
data. To obtain such distributions, we generate (W,A, T ) as above except now if A = 1 we add
to T an independently generated draw from a χ2 distribution with mean µ = 56, where µ was
calibrated to achieve θ = 14.9.
For each scenario and treatment effect θ ∈ {0, 14.9}, given (W,A, T ) we generate C based
on either a non-informative or informative censoring model. Specifically, the censoring time C is
generated based on drawing from the corresponding distribution gR(t, a, w) given below, for each
t ∈ {0, . . . , T − 1} in turn:
Non-Informative gR: logitP [Rt = 1|Jt = 1, A,W ] = −5.5 + 0.007t;
Informative gR: logitP [Rt = 1|Jt = 1, A,W ] = −6.5+0.007t+0.6W3A+0.3(W1+W5).
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The percentage of censored patients due to drop-out depends on the censoring model, treatment
effect and scenario. The non-informative and informative censoring distributions yield on average
62%–68% and 32%–38% censored patients due to drop-out, respectively (with values varying
within these intervals depending on θ and the scenario A-C). Though these are higher drop-out
rates than typically expected in a randomized trial, we evaluate performance under this substantial
censoring to illustrate that the estimators can have good performance even in this challenging
case. Assumptions (a)-(d) from Section 4.3 hold for all of our data generating distributions, while
independent censoring holds only under the non-informative censoring mechanism.
7.2 Estimators hˆ, gˆA, gˆR Used by the Adjusted Estimators
Each of hˆ, gˆA, gˆR is based on a logistic regression working model fit. The logistic regression
model for gA includes an intercept and a main term for each component of W . Since treatment
is assigned with P (A = 1|W ) = 0.5 for all simulated studies, the model for gA is correctly
specified. To account for censoring due to patient drop-out, the model for gR includes saturated
terms for time, treatment, and their interaction, in addition to main terms for W1 and W5 and a
treatment by W3 interaction. Therefore, the model for gR satisfies the condition in Theorem 2
and is correctly specified when the data is generated under either non-informative or informative
censoring. We use the long form data set to fit the model for gR, and set gˆR(m, a, w) = 0 for m
when the corresponding risk set is empty. The model for h consists of an intercept, main terms for
time (as a real value rather than categorical) and treatment, and treatment-time interaction, as well
as main terms for each component of W . For scenarios A and B, the data generating distribution
is based on resampling pairs W,T from the CLEAR III trial; therefore, the parametric model for h
is likely to be misspecified, which could easily occur in practice. However, in scenario C where T
is independent of W , the model for h is correctly specified.
7.3 Simulation Results
Tables 1 and 2 summarize the main results of our simulations, at sample sizes n = 500 and
n = 2000, respectively. Under non-informative censoring, where all the estimators are consistent,
all have relatively small bias. Under informative censoring and scenarios A and B (where the base-
line covariates are prognostic for the outcome), the Kaplan-Meier and unadjusted IPW estimators
are more biased compared to their adjusted counterparts. The informative censoring distribution
depends on baseline variables (W1,W3,W5), which under scenarios A and B are also correlated
with the outcome, therefore causing confounding and non-negligible bias even at the large sample
size (n = 2000); the bias is relatively small for scenario C, since censoring and the outcome do not
share any common causes.
We measure relative efficiency as the ratio of mean squared error (RMSE) comparing the
Kaplan-Meier estimator to each of the other estimators. First consider scenario A, where the corre-
lation betweenW and T mimics that from the CLEAR III trial data. The proposed estimator θˆadj,eff
has relative efficiency gains in the range 12%–14% compared to the Kaplan-Meier estimator, un-
der non-informative censoring. This means that a prespecified analysis plan using our proposed
TMLE could have required roughly 11% ≈ 1− (1/1.12) fewer patients (55 out of 500) to achieve
the same power; alternatively, the trial sample size could be conservatively planned assuming no
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precision gain, and then using θˆadj,eff would lead to increased power if baseline variables are prog-
nostic for the outcome. The efficiency gains of θˆadj,eff are similar under both types of censoring
at sample size n = 500. However, the gains are larger under informative censoring at n = 2000
(reaching 53% in one case); this is due to the bias of the unadjusted estimators (which, unlike the
adjusted estimators, are inconsistent) making a substantial contribution to the mean squared error
at the larger sample size.
Next consider scenario C, where baseline variables are independent of T . For this scenario,
all of the estimators are consistent under both censoring distributions. There are small losses
in relative MSE for the adjusted estimators, due to their introducing unnecessary variability by
adjusting for baseline variables unrelated to the outcome. These precision losses are generally
smaller at the larger sample size n = 2000 (Table 2) compared to n = 500.
The unadjusted IPW estimator has similar bias and variance as the Kaplan-Meier estimator, as
predicted by theory. The adjusted IPW estimator is not as efficient as the double robust estimators
AIPW and TMLE in scenarios A and B.
The TMLE θˆadj,eff has similar bias compared to the AIPW estimator. The TMLE variance is
slightly smaller, which translates into a relative MSE reduction of about 1% comparing the TMLE
to the AIPW estimator in scenarios A and B. The main advantages of the TMLE compared to
the AIPW estimator are: the TMLE has property (ii), i.e., guaranteed equal or better asymptotic
efficiency compared to the Kaplan-Meier estimator under independent censoring; the TMLE is
guaranteed to be within the bounds of the parameter space for θ. The latter property guarantees
that the estimated RMST for each study arm is nonnegative, which is not guaranteed for the AIPW
estimator; a negative RMST would be non-interpretable.
Using the R code in the Supplementary Materials, computation of the proposed estimator took
3.5 and 16.7 minutes for sample sizes 500 and 2000, respectively, for one of the simulated trials.
This computation time includes fitting the initial estimators for the event hazard, as well as the
censoring and the treatment mechanism. It was performed using R version 3.2.3 on a MacBook
Air with an Intel Core i5 1.3 GHz processor and 4GB of RAM.
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Table 1: Simulation results for studies of size n = 500. The bias, variance (VAR), and mean
squared error (MSE) are displayed for the Kaplan-Meier (KM), unadjusted inverse probability
weighted (Unadj.IPW), adjusted IPW (IPW), augmented IPW (AIPW) and proposed targeted min-
imum loss based (TMLE) estimator. The relative MSE (RMSE) is the ratio of the MSE for the KM
estimator to the other estimators.
Non-informative censoring
Zero Treatment Effect Positive Treatment Effect
Scenario Estimator Bias Var MSE RMSE Bias Var MSE RMSE
A
KM 0.031 35.23 35.23 1.000 0.013 26.54 26.54 1.000
Unadj.IPW 0.032 35.59 35.59 0.990 0.044 26.86 26.86 0.988
IPW 0.001 31.76 31.76 1.109 0.004 24.29 24.29 1.093
AIPW -0.020 31.22 31.21 1.128 -0.027 23.95 23.95 1.108
TMLE -0.019 30.96 30.96 1.138 -0.074 23.74 23.74 1.118
B
KM 0.062 36.09 36.09 1.000 -0.059 27.40 27.40 1.000
Unadj.IPW 0.063 36.46 36.46 0.990 -0.029 27.72 27.72 0.988
IPW 0.069 35.89 35.89 1.005 -0.046 27.26 27.26 1.005
AIPW 0.069 35.56 35.56 1.015 -0.087 26.94 26.94 1.017
TMLE 0.069 35.27 35.27 1.023 -0.133 26.71 26.73 1.025
C
KM -0.048 35.52 35.52 1.000 -0.035 26.91 26.91 1.000
Unadj.IPW -0.048 35.90 35.90 0.989 -0.004 27.22 27.22 0.989
IPW -0.046 36.41 36.41 0.976 -0.013 27.50 27.50 0.978
AIPW -0.046 36.05 36.05 0.985 -0.048 27.23 27.23 0.988
TMLE -0.046 35.76 35.76 0.993 -0.092 27.00 27.01 0.996
Informative censoring
Zero Treatment Effect Positive Treatment Effect
Scenario Estimator Bias Var MSE RMSE Bias Var MSE RMSE
A
KM 0.802 31.48 32.12 1.000 1.760 22.48 25.58 1.000
Unadj.IPW 0.794 31.61 32.25 0.996 1.775 22.59 25.73 0.994
IPW -0.108 29.48 29.49 1.089 0.079 22.92 22.93 1.116
AIPW -0.045 29.22 29.22 1.099 0.097 22.44 22.44 1.140
TMLE -0.044 29.08 29.08 1.105 0.045 22.18 22.18 1.153
B
KM 0.368 33.25 33.38 1.000 0.882 23.12 23.90 1.000
Unadj.IPW 0.357 33.34 33.52 0.996 0.893 23.23 24.03 0.994
IPW -0.084 33.68 33.68 0.991 0.046 24.31 24.31 0.983
AIPW -0.050 33.36 33.36 1.000 0.056 24.13 24.13 0.990
TMLE -0.050 33.09 33.09 1.009 0.004 23.93 23.92 0.999
C
KM 0.039 31.88 31.88 1.000 0.039 24.02 24.02 1.000
Unadj.IPW 0.025 32.02 32.02 0.996 0.046 24.13 24.13 0.995
IPW 0.022 32.66 32.66 0.976 0.053 24.90 24.90 0.965
AIPW 0.041 32.51 32.51 0.980 0.051 24.77 24.77 0.970
TMLE 0.041 32.24 32.24 0.989 0.001 24.65 24.65 0.974
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Table 2: Simulation results for studies of size n = 2000. The bias, variance (VAR), and mean
squared error (MSE) are displayed for the Kaplan-Meier (KM), unadjusted inverse probability
weighted (Unadj.IPW), adjusted IPW (IPW), augmented IPW (AIPW) and proposed targeted min-
imum loss based (TMLE) estimator. The relative MSE (RMSE) is the ratio of the MSE for the KM
estimator to the other estimators.
Non-informative censoring
Zero Treatment Effect Positive Treatment Effect
Scenario Estimator Bias Var MSE RMSE Bias Var MSE RMSE
A
KM -0.069 8.86 8.86 1.000 -0.015 6.79 6.79 1.000
Unadj.IPW -0.070 8.95 8.96 0.990 0.016 6.87 6.87 0.988
IPW -0.057 8.04 8.04 1.102 0.027 6.12 6.12 1.110
AIPW -0.052 7.88 7.88 1.125 -0.015 6.00 6.00 1.133
TMLE -0.051 7.81 7.81 1.134 -0.060 5.95 5.95 1.142
B
KM 0.022 8.92 8.92 1.000 -0.060 6.68 6.68 1.000
Unadj.IPW 0.022 9.01 9.01 0.990 -0.029 6.76 6.76 0.989
IPW 0.019 8.77 8.77 1.018 -0.033 6.60 6.60 1.012
AIPW 0.017 8.69 8.69 1.027 -0.075 6.50 6.51 1.027
TMLE 0.017 8.62 8.62 1.035 -0.119 6.45 6.46 1.035
C
KM -0.008 8.78 8.78 1.000 -0.035 6.77 6.77 1.000
Unadj.IPW -0.008 8.87 8.87 0.990 -0.004 6.85 6.85 0.989
IPW -0.008 8.91 8.91 0.986 -0.005 6.87 6.87 0.986
AIPW -0.009 8.82 8.82 0.996 -0.048 6.80 6.80 0.996
TMLE -0.009 8.82 8.82 0.996 -0.038 6.79 6.79 0.997
Informative censoring
Zero Treatment Effect Positive Treatment Effect
Scenario Estimator Bias Var MSE RMSE Bias Var MSE RMSE
A
KM 0.797 7.78 8.42 1.000 1.646 5.65 8.36 1.000
Unadj.IPW 0.790 7.82 8.44 0.997 1.661 5.68 8.44 0.991
IPW -0.082 7.32 7.32 1.150 -0.041 5.66 5.67 1.478
AIPW -0.022 7.20 7.20 1.168 -0.012 5.53 5.53 1.513
TMLE -0.023 7.15 7.15 1.178 -0.057 5.48 5.48 1.526
B
KM 0.407 8.08 8.24 1.000 0.863 5.76 6.50 1.000
Unadj.IPW 0.396 8.12 8.27 0.997 0.875 5.78 6.55 0.993
IPW -0.054 8.15 8.15 1.011 0.012 6.05 6.05 1.075
AIPW -0.016 8.08 8.08 1.020 0.020 5.98 5.98 1.087
TMLE -0.016 8.02 8.02 1.028 -0.024 5.93 5.93 1.097
C
KM -0.012 8.12 8.12 1.000 -0.006 5.85 5.85 1.000
Unadj.IPW -0.025 8.16 8.16 0.995 0.002 5.88 5.88 0.995
IPW -0.028 8.23 8.23 0.987 -0.010 5.98 5.98 0.978
AIPW -0.009 8.19 8.19 0.992 -0.015 5.96 5.95 0.983
TMLE -0.009 8.12 8.12 1.000 -0.061 5.90 5.91 0.991
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8 Discussion
Under random censoring, our estimator is consistent if either the outcome or censoring model is
correctly specified, i.e., our estimator is doubly robust. This is in contrast to the proportional hazard
model, which relies exclusively on assumptions on the outcome model. When the dimension of
the baseline variables is large relative to the sample size, the curse of dimensionality precludes
the use of nonparametric estimators or saturated parametric models (Robins and Ritov, 1997). A
potential way to address this is to incorporate data-adaptive model selection in constructing the
initial estimators in step 1 of the TMLE procedure, such as model stacking (Wolpert, 1992) or
super learning (van der Laan et al., 2007). The asymptotic properties of the resulting estimator
then require conditions (f)-(g) in Theorem 3 of the Supplementary Materials. These conditions
would hold automatically for the MLE in a parametric model, but need to be verified for data-
adaptive estimators. van der Laan (2014) proposed an estimator for the case of a cross-sectional
study that relaxes assumption (f), and we conjecture that this approach might be generalizable to
our problem.
In our presentation of the TMLE algorithm we have assumed that the initial estimators gˆR and
gˆA contain saturated terms for treatment, time, and their interaction. When using data-adaptive
methods, such restriction can be avoided by including the aforementioned saturated terms in the
logistic regression models (20)-(21) in step 2 of the TMLE algorithm.
Precision gains from adjustment for prognostic baseline variables can be converted into shorter
duration trials by using information monitoring. That is, the trial continues until a prespecified in-
formation level is achieved. Since improved precision implies (asymptotically) a faster information
accrual rate, the trial duration may be shorter.
Our method assumes that censoring is confounded with the time to event only by baseline
variables. In the presence of time dependent confounding between censoring and the event time,
our proposal may be adapted by augmenting the censoring and outcome models to include time-
varying confounders. It may be possible to retain the properties (i)-(iv) in this context by extending
the proof techniques from the Supplementary Materials. These properties are still relevant under
time dependent confounding, since the use of proportional hazard models often yields biased esti-
mators in this context, as discussed by Cole et al. (2003).
We defined independent censoring as C⊥⊥(Ta,W ) | A. Another possible definition of inde-
pendent censoring, which is more commonly used when discussing the unadjusted estimator, is
C⊥⊥Ta | A (which leaves out W altogether). The latter assumption is weaker (less restrictive)
than the former. The covariate adjustment method of Zhang (2014) guarantees enhanced effi-
ciency properties under the latter definition. Our TMLE estimator requires the former definition
to achieve the enhanced efficiency property (ii). On the other hand, our TMLE estimator has the
advantage over Zhang (2014) and θˆkm of remaining consistent under violations to the assumption
that C⊥⊥Ta | A, as long as random censoring holds and at least one of the censoring or survival
distributions is consistently estimated.
Most clinical research studies use discrete time scales to measure the time to event. If time
is measured on a continuous scale, implementation of our methods requires discretization. The
specific choice of the discretization intervals may be guided by what is clinically relevant. For
example, in clinical applications with time to death outcomes, the clinically relevant scale would
typically be a day. In the absence of clinical criteria to guide the choice of discretization level, a
concern is that too coarse of a discretization may lead to potentially meaningful information losses.
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A question for future research is how to optimally set the level of discretization in order to trade
off information loss versus estimator precision. Another area for future research is to consider
discretization levels that get finer with sample size.
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